support@micropace.com.au +61 02 9718 1746

Pace, Measure, Analyse

OneStim™ CRM

The OneStim-CRM™ provides, in one device, the key functionality recommended for implanting conduction system pacing leads according to the 2023 EHRA clinical consensus statement on conduction system pacing implantation [1], namely:

  1. Voltage controlled pacing
  2. Continuous impedance measurements
  3. Current of Injury display, and
  4. 12 Lead ECG display and measurement.

Features

Continuous impedance with graph

Full 12 ECG display

Trigger screen with automatic measurements - RWPT, V6-V1 Int

Paced extras

Template comparison

Review screen with multiple callipers



OneStim™ CRM Specifications

Patient Interface


  • 2 intra-cardiac channels
  • 12-13 lead surface ECG
  • 1 independent emergency pacing channel



Programmable Stimulation


  • Pace, A-V Delay, Nodal ERP R-synced Sx, Threshold
  • 0.1-25V (50V in esophageal mode)
  • 0.1-25mA


ECG Analysis & Reporting

  • Up to 90s buffer of saved ECG for review at sweep speed up to 400mm/s
  • Time and amplitude measurement callipers (±1ms, ±0.1mV)
  • Triggered sweep
  • Template comparison
  • Save printable reports
 

Training Videos

 

 







 

Reference:
[1] Burri, H., Jastrzebski, M., Cano, Ó., Čurila, K., de Pooter, J., Huang, W., Israel, C., Joza, J., Romero, J., Vernooy, K., Vijayaraman, P., Whinnett, Z., & Zanon, F. (2023). EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace, 25(4), 1208–1236.